ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 100 filers reported holding ATOSSA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $29,000 | -79.3% | 34,788 | -68.9% | 0.00% | -100.0% |
| Q1 2022 | $140,000 | -32.7% | 111,898 | -13.9% | 0.00% | -40.0% |
| Q4 2021 | $208,000 | -32.9% | 129,916 | +36.8% | 0.01% | -16.7% |
| Q3 2021 | $310,000 | +656.1% | 94,950 | +461.8% | 0.01% | +500.0% |
| Q3 2020 | $41,000 | – | 16,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 347,392 | $256 | 0.02% |
| XTX Topco Ltd | 167,427 | $123,310 | 0.02% |
| Laurion Capital Management LP | 2,225,800 | $1,639,302 | 0.01% |
| Virtu Financial LLC | 80,728 | $59 | 0.01% |
| Renaissance Technologies | 1,242,370 | $915 | 0.00% |
| LVM CAPITAL MANAGEMENT LTD/MI | 21,000 | $15 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 50,000 | $36,825 | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 133,591 | $98,390 | 0.00% |
| Caption Management, LLC | 75,000 | $55,238 | 0.00% |
| J. L. Bainbridge & Co., Inc. | 11,121 | $8,191 | 0.00% |